Research graph
References from Single nucleotide and copy number variants of cancer driver genes inform drug response in multiple cancers. Local targets link to admitted publications; unresolved targets remain external evidence.
Precision-medicine plan raises hopes: US initiative highlights growing focus on targeted therapies
2015 · External reference
Cancer treatment model with the Caputo-Fabrizio fractional derivative
10.1140/epjp/i2018-11950-y · 2018 · External reference
Global cancer statistics, 2012
2015 · External reference
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
10.1371/journal.pmed.1001789 · 2015 · External reference
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
10.1038/nature11003 · 2012 · External reference
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
10.1093/nar/gks1111 · 2012 · External reference
Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties
10.1371/journal.pone.0061318 · 2013 · External reference
Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization
10.1021/ci500152b · 2014 · External reference
Current trends in drug sensitivity prediction
10.2174/1381612822666161026154430 · 2016 · External reference
Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model
10.1371/journal.pcbi.1004498 · 2015 · External reference
DRdriver: identifying drug resistance driver genes using individual-specific gene regulatory network
10.1093/bib/bbad066 · 2023 · External reference
Gamma distribution based predicting model for breast cancer drug response based on multi-layer feature selection
10.3389/fgene.2023.1095976 · 2023 · External reference
A convergence-based framework for cancer drug resistance
10.1016/j.ccell.2018.03.025 · 2018 · External reference
Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
10.1016/j.lungcan.2017.09.005 · 2017 · External reference
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
10.1158/2159-8290.cd-13-0617 · 2014 · External reference
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
10.1038/s41467-022-33870-0 · 2022 · External reference
Machine learning approaches to drug response prediction: challenges and recent progress
10.1038/s41698-020-0122-1 · 2020 · External reference
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
10.1038/s41568-018-0060-1 · 2018 · External reference
T test as a parametric statistic
10.4097/kjae.2015.68.6.540 · 2015 · External reference
The Box-Cox transformation technique: a review
1992 · External reference
A new family of power transformations to improve normality or symmetry
10.1093/biomet/87.4.954 · 2000 · External reference
The Kolmogorov-Smirnov test for goodness of fit
10.1080/01621459.1951.10500769 · 1951 · External reference
Posterior predictive p-values
1994 · External reference
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
10.1038/ng1071 · 2003 · External reference
OncoKB: a precision oncology knowledge base
10.1200/po.17.00011 · 2017 · External reference
